Certified by Founder Lodge
Renibus Therapeutics Inc
United States - Southlake, Texas
START UP
1 Disclosed Funding Rounds $47,000,000
0 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Renibus is a clinical stage biopharmaceutical company dedicated to treating, improving and extending patients’ lives by developing breakthrough products to prevent disease progression, improv
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| July, 19 ,2023 | Series B | $47,000,000 | |
| September, 13 ,2023 | Series B | Undisclosed Amount |
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Katalist | $1,500,000 | (Dec 19, 2025)
Amphix Bio | $12,500,000 | (Dec 19, 2025)
Neural Concept | $100,000,000 | (Dec 19, 2025)
Gravity Labs Co., Ltd. | $17,000,000 | (Dec 19, 2025)
arcads AI | $16,000,000 | (Dec 19, 2025)
